an italian private-owned pharmaceutical company, founded in 1892 in Florence.
Molteni is active in the development, manufacturing and marketing of finished pharmaceutical products in different strenghts and formulations.
Molteni’s mainly deal with controlled drug substances of finished products in pain and addiction treatment.
The company is growing at international level with agreements with qualified local partner/distributors, out-licensing agreements and thanks to a direct presence in Poland since 1994.
In 2018 Molteni finalized an agreement regarding an innovative implant product (SIXMO) containing buprenorphine for long treatment of heroin addiction. Molteni acquired rights of for EU and some other countries outside EU (among them Russia and Iran).
SIXMO was registered at EMA (European level), last June 2019.
Western Europe; Eastern Europe; Middle East; Asia; Australia; North America; Africa; Central/South America
Are you a supplier
Here's what we can do for you
- Generate quality leads for your business
- Stay visible for 365 days of the year
- Receive product inquiries and respond to meeting requests directly
- Improve company online presence through Search Engine Optimisation